Is Aditxt, Inc. (ADTX) Halal?

NASDAQ Healthcare United States $419,463
✗ NOT HALAL
Confidence: 90/100
Aditxt, Inc. (ADTX) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 6695.2% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. Aditxt, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 6695.2%
/ 30%
805.9%
/ 30%
1114.7%
/ 30%
1.09%
/ 5%
✗ NOT HALAL
DJIM 6695.2%
/ 33%
805.9%
/ 33%
1114.7%
/ 33%
1.09%
/ 5%
✗ NOT HALAL
MSCI 21.5%
/ 33%
2.6%
/ 33%
3.6%
/ 33%
1.09%
/ 5%
✓ HALAL
S&P 6695.2%
/ 33%
805.9%
/ 33%
1114.7%
/ 33%
1.09%
/ 5%
✗ NOT HALAL
FTSE 21.5%
/ 33%
2.6%
/ 33%
3.6%
/ 50%
1.09%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-6,637.20
P/B Ratio
-0.0
EV/EBITDA
-0.2
EV: $4M
Revenue
$133,985
Growth: -89.1%
Beta
1.2
Average volatility
Current Ratio
0.0

Profitability

Gross Margin 0.0%
Operating Margin -419870.3%
Net Margin 0.0%
Return on Assets (ROA) -61.7%

Cash Flow & Balance Sheet

Operating Cash Flow-$17M
Free Cash Flow-$17M
Total Debt$7M
Current Ratio0.0
Total Assets$32M

Price & Trading

Last Close$0.88
50-Day MA$4.49
200-Day MA$444.60
Avg Volume214K
Beta1.2
52-Week Range
$0.80
$5,215.18

About Aditxt, Inc. (ADTX)

CEO
Mr. Amro A. Albanna
Employees
26
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NASDAQ
Market Cap
$419,463
Currency
USD

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Aditxt, Inc. (ADTX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Aditxt, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Aditxt, Inc.'s debt ratio?

Aditxt, Inc.'s debt ratio is 6695.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.5%.

What are Aditxt, Inc.'s key financial metrics?

Aditxt, Inc. has a market capitalization of $419,463, and revenue of $133,985.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.